MDS

NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen Cytopenia panel as part of the diagnostic…

WINTERSET, Iowa — For 35 years, this town’s residents have brought all manner of illnesses, aches, and worries to Kevin de Regnier’s storefront clinic on the…

Quality and cost of care were similar between allopathic (MD) and osteopathic…

CHICAGO -- Patients with transfusion-dependent, low-risk myelodysplastic syndromes (MDS) needed significantly…

Editor's Note: Welcome to SocialBreak, a new weekly roundup from MedPage Today, where we'll…

Another potential risk from prenatal exposure to thalidomide when it was used as an…

Patients treated in dose-escalation portion of Phase 1/2 study evaluating seclidemstat in combination with azacitidine 50% overall response rate among eight myelodysplastic syndrome (MDS)…

The investigational anti-CD47 monoclonal antibody magrolimab combined with azacitidine showed promising efficacy and was well…

- 141 MDS Patients Enrolled -- Topline Data Anticipated 1H:2023 - SAN FRANCISCO, Aug. 26, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced completion of patient…

Low-dose hypomethylating agents (HMAs) was associated with favorable outcomes in previously…